v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)    
Revenue $ 365,471  
Cost of goods sold 238,592  
Operating expenses:    
General and administrative expenses 4,763,716 $ 1,110,229
Research and development expenses 1,018,352 875,342
Depreciation and amortization 8,215 8,119
Total operating expenses 5,790,283 1,993,690
Loss from operations (5,663,404) (1,993,690)
Other income (expense):    
Change in fair value of derivative liabilities (827,445) (541,639)
Change in fair value of warrant liabilities 223,162 (13,043,192)
Change in earnout liability (30,000)  
Transaction costs expensed (9,665,004)  
Gain on settlement of forward purchase agreement 1,406,669  
Interest expense (723,467) (2,872,951)
Other income   14,019
Gains from extinguishment of debt, net 12,592,052  
Total other income (expense): 2,975,967 (16,443,763)
Loss before income taxes (2,687,437) (18,437,453)
Net income (loss) $ (2,687,437) $ (18,437,453)
Net loss per share/unit:    
Basic (in dollars per share) $ (0.12) $ (0.09)
Diluted (in dollars per share) $ (0.12) $ (0.09)
Weighted average number of shares/units:    
Basic (in shares) 23,198,658 220,025,101
Diluted (in shares) 23,198,658 220,025,101